• 1
    Montagna W. Comparative aspects of sebaceous glands. In: MontagnaW, EllisR A, SilverA F, eds. Advances in Biology of Skin. Vol IV. The Sebaceous Glands. Oxford: Pergamon Press, 1963: 3245.
  • 2
    Nikkari T. Comparative chemistry of sebum. J Invest Dermatol 1974: 62: 257267.
  • 3
    Pochi P. The sebaceous gland. In: MaibachH I, BoisitsE K, eds. Neonatal Skin Structure and Function. New York: Marcel Dekker, 1982: 6780.
  • 4
    Mykytowycz R, Goodrich B S. Skin glands as organs of communication in mammals. J Invest Dermatol 1974: 62: 124131.
  • 5
    Ebling F J G, Cunliffe W J. Disorders of the sebaceous glands. In: ChampionR H, BurtonJ L, EblingF J G, eds. Textbook of Dermatology, 5th edn. London: Blackwell, 1992: 16991744.
  • 6
    Wheatley V R. Sebum: its chemistry and biochemistry. Am Perfumer 1956: 68: 3747.
  • 7
    Thody A J, Shuster S. Control and function of sebaceous glands. Physiol Rev 1989: 69: 383416.
  • 8
    Kligman A M. The uses of sebum? In: MontagnaW, EllisR A, SilverA F, eds. Advances in Biology of Skin. Vol IV. The Sebaceous Glands. Oxford: Pergamon Press, 1963: 110112.
  • 9
    Cunliffe W J. Acne. London: Martin Dunitz, 1989.
  • 10
    Zouboulis C C. Sebaceous gland in human skin – the fantastic future of a skin appendage. J Invest Dermatol 2003: 120: xivxv.
  • 11
    Xia L, Zouboulis C, Detmar M, Mayer-da-Silva A, Stadler R, Orfanos C E. Isolation of human sebaceous glands and cultivation of sebaceous gland-derived cells as an in-vitro model. J Invest Dermatol 1989: 93: 315321.
  • 12
    Zouboulis C C, Xia L, Akamatsu H et al. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology 1998: 196: 2131.
  • 13
    Zouboulis C C, Seltmann H, Neitzel H, Orfanos C E. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 1999: 113: 10111020.
  • 14
    Thiboutot D, Jabara S, McAllister J et al. Human skin is a steroidogenic tissue: Steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol 2003: 120: 905914.
  • 15
    Zouboulis C C, Fimmel S, Ortmann J, Turnbull J R, Boschnakow A. Sebaceous glands. In: HoathS B, MaibachH I, eds. Neonatal Skin – Structure and Function, 2nd edn. New York Basel: Marcel Dekker, 2003: 5988.
  • 16
    Pilgram G S, Van Der Meulen J, Gooris G S, Koerten H K, Bouwstra J A. The influence of two azones and sebaceous lipids on the lateral organization of lipids isolated from human stratum corneum. Biochim Biophys Acta 2001: 1511: 244254.
  • 17
    Fluhr J W, Mao-Qiang M, Brown B E et al. Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J Invest Dermatol 2003: 120: 728737.
  • 18
    Selleri S, Seltmann H, Gariboldi S et al. Doxorubicin-induced alopecia is associated with sebaceous gland differentiation. J Invest Dermatol 2006: 126: 711720.
  • 19
    Winiarska A, Mandt N, Kamp H et al. Effect of 5alpha-dihydrotestosterone and testosterone on apoptosis in human dermal papilla cells. Skin Pharmacol Physiol 2006: 19: 311321.
  • 20
    Thiele J J, Weber S U, Packer L. Sebaceous gland secretion is a major physiologic route of vitamin E delivery to skin. J Invest Dermatol 1999: 113: 10061010.
  • 21
    Marques M, Pei Y, Southall M D et al. Identification of platelet-activating factor acetylhydrolase II in human skin. J Invest Dermatol 2002: 119: 913919.
  • 22
    Kosaka S, Kawana S, Zouboulis C C, Hasan T, Ortel B. Targeting of sebocytes by aminolevulinic acid-dependent photosensitization. Photochem Photobiol 2006: 82: 453457.
  • 23
    Wróbel A, Seltmann H, Fimmel S et al. Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol 2003: 120: 175181.
  • 24
    Alestas T, Ganceviciene R, Fimmel S, Müller-Decker K, Zouboulis C C. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med 2006: 84: 7587.
  • 25
    Zhang Q, Seltmann H, Zouboulis C C, Travers J B. Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production. Exp Dermatol 2006: 15: 769774.
  • 26
    Zhang Q, Seltmann H, Zouboulis C C, Konger R L. Involvement of PPAR-gamma in oxidative stress-mediated prostaglandin E2 production in SZ95 human sebaceous gland cells. J Invest Dermatol 2006: 126: 4248.
  • 27
    Russell L E, Harrison W J, Bahta A W, Zouboulis C C, Burrin J M, Philpott M P. Characterization of liver X receptor expression and function in human skin and the pilosebaceous unit. Exp Dermatol 2007: 16: 844852.
  • 28
    Hong I, Lee M-H, Na T-Y, Zouboulis C C, Lee M O. LXRα enhances lipid synthesis in SZ95 sebocytes. J Invest Dermatol (Epub ahead of print, 2007, Oct 25).
  • 29
    Wille J J, Kydonieus A. Palmitoleic acid isomer (C16:1Δ6) is the active antimicrobial fatty acid in human skin sebum. Skin Pharmacol Appl Skin Physiol 2003: 16: 176187.
  • 30
    Georgel P, Crozat K, Lauth X et al. A TLR2-responsive lipid effector pathway protects mammals against Gram-positive bacterial skin infections. Infect Immun 2005: 73: 45124521.
  • 31
    Gebhart W, Metze D, Jurecka W, Schmidt J B. Immunglobulin A in Talgdrüsen. Wien Klin Wochenschr 1986: 98: 683689.
  • 32
    Boehm K D, Yun J K, Strohl K P, Elmets C A. Messenger RNAs for the multifunctional cytokines interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha are present in adnexal tissues and in dermis of normal human skin. Exp Dermatol 1995: 4: 335341.
  • 33
    Nagy I, Pivarcsi A, Kis K et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antibacterial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 2006: 8: 21952205.
  • 34
    Lee D-Y, Yamasaki K, Zouboulis C C, Park G T, Yang J-M, Gallo R L. Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill Propionibacterium acnes. J Invest Dermatol (Epub ahead of print, 2008, Jan 17).
  • 35
    Zouboulis C C. The human skin as a hormone target and an endocrine gland. Hormones 2004: 3: 926.
  • 36
    Zouboulis C C, Chen W, Thornton M J, Qin K, Rosenfield R L. Sexual hormones in human skin. Horm Metab Res 2007: 39: 8595.
  • 37
    Fritsch M, Orfanos C E, Zouboulis C C. Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol 2001: 116: 793800.
  • 38
    Makrantonaki E, Adjaye J, Herwig R et al. Age-specific hormonal decline is accompanied by transcriptional changes in human sebocytes in vitro. Aging Cell 2006: 5: 331344.
  • 39
    Makrantonaki E, Zouboulis C C. The skin as a mirror of the aging process in the human organism – state of the art and results of the aging research in the German National Genome Research Network 2 (NGFN-2). Exp Gerontol 2007: 42: 879886.
  • 40
    Rhein L D, Zatz J L, Motwani M R. Sebum: physical-chemical properties, macromolecular structure, and effects of ingredients. In: WebsterG F, RawlingsA V, eds. Acne and its Therapy. New York, London: Informa Healthcare, 2007: 203222.
  • 41
    Makrantonaki E, Zouboulis C C. Testosterone metabolism to 5α-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferators-activated receptor ligand linoleic acid in human sebocytes. Brit J Dermatol 2007: 156: 428432.
  • 42
    Zouboulis C C, Chen W, Alestas T, Makrantonaki E, Seltmann H, Müller-Decker K. Sexual hormones utilize complex mechanisms to modulate sebocyte differentiation. Exp Dermatol 2005: 14: 156.
  • 43
    Pelle E, McCarthy J, Seltmann H et al. Identification of histamine receptors and reduction of squalene levels by an antihistamine in sebocytes. J Invest Dermatol (Epub ahead of print, 2007, Nov 15).
  • 44
    Akamatsu H, Zouboulis C C, Orfanos C E. Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of sebaceous glands. J Invest Dermatol 1992: 99: 509511.
  • 45
    Tsukada M, Schröder M, Roos T C et al. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol 2000: 115: 321327.
  • 46
    Fimmel S, Zouboulis C C. Influence of physiological androgen levels on wound healing and immune status in men. Aging Male 2005: 8: 166174.
  • 47
    Niemann C, Unden A B, Lyle S, Zouboulis C C, Toftgård R, Watt F M. Indian hedgehog and β-catenin signaling: Role in the sebaceous lineage of normal and neoplastic mammalian epidermis. Proc Natl Acad Sci U S A 2003: 100 (Suppl. 1): 1187311880.
  • 48
    Lo Celso C, Braun K M, Frye M, Berta M, Zouboulis C C, Watt F M. Characterisation of bipotential epidermal progenitors for sebaceous gland and interfollicular epidermis: contrasting roles of c-Myc and β-catenin. Stem Cells (Epub ahead of print, 2008, Feb 28).
  • 49
    Ziegler C G, Krug A W, Zouboulis C C, Bornstein S R. Corticotropin releasing hormone and it’s function in the skin. Horm Metab Res 2007: 39: 106109.
  • 50
    Zouboulis C C, Böhm M. Neuroendocrine regulation of sebocytes – a pathogenetic link between stress and acne. Exp Dermatol 2004: 13 (Suppl. 4): 3135.
  • 51
    Slominski A T, Botchkarev V, Choudhry M et al. Cutaneous expression of CRH and CRH-R. Is there a ‘skin stress response system?’ Ann NY Acad Sci 1999: 885: 287311.
  • 52
    Kono M, Nagata H, Umemura S, Kawana S, Yoshiyuki R. In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J 2001: 15: 22972299.
  • 53
    Wollina U, Abdel-Naser M B, Ganceviciene R, Zouboulis C C. Receptors of eccrine, apocrine and holocrine skin glands. Dermatol Clin 2007: 25: 577588.
  • 54
    Zouboulis C C, Seltmann H, Hiroi N et al. Corticotropin releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A 2002: 99: 71487153.
  • 55
    Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis C C. Corticotropin-releasing hormone skin signalling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res 2007: 39: 166170.
  • 56
    Ganceviciene R, Marciukaitiene I, Graziene V, Rimkevicius A, Zouboulis C C. New accents in the pathogenesis of acne vulgaris. Acta Medica Lituanica 2006: 13: 8387.
  • 57
    Böhm M, Luger T A. Neurobiology of sebaceous glands. In: GransteinR D, LugerT A, eds. Neuroimmunology of the Skin. Basic Science to Clinical Relevance. Heidelberg: Springer, in press.
  • 58
    Böhm M, Schiller M, Stander S et al. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002: 118: 533539.
  • 59
    Zhang L, Anthonavage M, Huang Q, Li W H, Eisinger M. Proopiomelanocortin peptides and sebogenesis. Ann N Y Acad Sci 2003: 994: 154161.
  • 60
    Zhang L, Li W-H, Anthonavage M, Eisinger M. Melanocortin-5 receptor: a marker of human sebocyte differentiation. Peptides 2006: 27: 413420.
  • 61
    Thiboutot D, Sivarajah A, Gilliland K, Cong Z, Clawson G. The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells. J Invest Dermatol 2001: 115: 614619.
  • 62
    Hatta N, Dixon C, Ray A J et al. Expression, candidate gene, and population studies of the melanocortin 5 receptor. J Invest Dermatol 2001: 116: 564570.
  • 63
    Jeong S K, Hwang S W, Choi S Y et al. Intracellular calcium mobilization is mediated by melanocortin receptors in SZ95 sebocytes. J Invest Dermatol 2007: 127: S72 (abstract).
  • 64
    Chen W, Kelly M A, Opitz-Araya X, Thomas R E, Low M J, Cone R D. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 1997: 91: 789798.
  • 65
    Ganceviciene R, Graziene V, Böhm M, Zouboulis C C. Increased in situ expression of melanocortin-1 receptor in sebaceous glands of lesional skin of patients with acne vulgaris. Exp Dermatol 2007: 16: 547552.
  • 66
    Böhm M, Li Z, Ottaviani M et al. Beta-endorphin modulates lipogenesis in human sebocytes. J Invest Dermatol 2004: 123: A10 (abstract).
  • 67
    Slominski A, Wortman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000: 80: 9791020.
  • 68
    Kim H S, Cho D H, Kim H J, Lee J Y, Cho B K, Park H J. Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropin and α-melanocyte-stimulating hormone in alopecia areata. Exp Dermatol 2006: 15: 515522.
  • 69
    Grando S A, Pittelkow M R, Schallreuter K U. Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J Invest Dermatol 2006: 126: 19481965.
  • 70
    Kurzen H, Berger H, Jäger C et al. Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin. J Invest Dermatol 2004: 123: 937949.
  • 71
    Hana A, Booken D, Henrich C et al. Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci 2007: 80: 22142220.
  • 72
    Schafer T, Nienhaus A, Vieluf D, Berger J, Ring J. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001: 145: 100104.
  • 73
    Klaz I, Kochba I, Shohat T, Zarka S, Brenner S. Severe acne vulgaris and tobacco smoking in young men. J Invest Dermatol 2006: 126: 17491752.
  • 74
    Toyoda M, Nakamura M, Makino T, Kagoura M, Morohashi M. Sebaceous glands in acne patients express high levels of neutral endopeptidase. Exp Dermatol 2002: 11: 241247.
  • 75
    Thielitz A, Reinhold D, Vetter R et al. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) target major pathogenetic steps in acne initiation. J Invest Dermatol 2007: 127: 10421051.
  • 76
    Fleischer B. CD26: a surface protease involved in T-cell activation. Immunol Today 1994: 15: 180184.
  • 77
    Ansorge S, Reinhold D. Immune peptides related to dipeptidyl aminopeptidase IV/CD26. In: KastinA J, ed. Handbook of Biologically Active Peptides. Amsterdam: Academic Press Elsevier, 2006: 567572.
  • 78
    Zouboulis C C. Acne vulgaris and rosacea. In: GransteinR D, LugerT A, eds. Neuroimmunology of the Skin. Basic Science to Clinical Relevance. Heidelberg: Springer, in press.
  • 79
    Riemann D, Kehlen A, Langner J. CD13 – not just a marker in leukemia typing. Immunol Today 1999: 20: 8388.
  • 80
    De Meester I, Korom S, Van Damme J, Scharpe S. CD26, let it cut or cut it down. Immunol Today 1999: 20: 367375.
  • 81
    Reinhold D, Kähne T, Steinbrecher A et al. The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity. Biol Chem 2002: 383: 11331138.
  • 82
    Hunyadi J, Simon M Jr, Kenderessy A S, Dobozy A. Expression of monocyte/macrophage markers (CD13, CD14, CD68) on human keratinocytes in healthy and diseased skin. J Dermatol 1993: 20: 341345.
  • 83
    Novelli M, Savoia P, Fierro M T, Verrone A, Quaglino P, Bernengo M G. Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases. Br J Dermatol 1996: 134: 10521056.
  • 84
    Reinhold D, Vetter R W, Mnich K et al. Dipeptidyl peptidase IV (DP IV, CD26) is involved in regulation of DNA synthesis in human keratinocytes. FEBS Lett 1998: 428: 100104.
  • 85
    Thielitz A, Bukowska A, Wolke C et al. Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation. Biochem Biophys Res Commun 2004: 321: 795801.
  • 86
    Holick M F. Evolution and function of vitamin D. Recent Results Cancer Res 2003: 164: 328.
  • 87
    Nebert D W, Gonzalez F J. P450 genes: structure, evolution, and regulation. Ann Rev Biochem 1987: 56: 945993.
  • 88
    Henry H L. Vitamin D hydroxylase. J Cell Biochem 1992: 49: 49.
  • 89
    Lehmann B, Querings K, Reichrath J. Vitamin D and skin: new aspects for dermatology. Exp Dermatol 2004: 13(s4): 1115.
  • 90
    Reichrath J, Rafi L, Rech M et al. Analysis of the vitamin D system in cutaneous squamous cell carcinomas (SCC). J Cut Pathol 2004: 31: 224231.
  • 91
    Chen W, Yang C-C, Sheu H-M, Seltmann H, Zouboulis C C. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 2003: 121: 441447.
  • 92
    Reichrath J, Schuler C, Seifert M, Zouboulis C C, Tilgen W. The vitamin D endocrine system in human sebocytes. Exp Dermatol 2006: 15: 643 (abstract).
  • 93
    Gollnick H. Current concepts of the pathogenesis of acne: implications for drug treatment. Drugs 2003: 63: 15791596.
  • 94
    Zouboulis C C. Isotretinoin revisited – pluripotent effects on human sebaceous gland cells. J Invest Dermatol 2006: 126: 21542156.
  • 95
    Baron J M, Heise R, Blaner W et al. Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol 2005: 125: 143153.
  • 96
    Duell E A, Åstrom A, Griffiths C E, Chambon P, Voorhees J J. Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro. J Clin Invest 1992: 4: 12691274.
  • 97
    Sorg O, Antille C, Kaya G, Saurat J H. Retinoids in cosmeceuticals. Dermatol Ther 2006: 9: 289296.
  • 98
    Smith G, Wolf C R, Deeni Y Y et al. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 2003: 361: 13361343.
  • 99
    Heise R, Mey J, Neis M et al. Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D-skin models. J Invest Dermatol 2006: 126: 24732480.
  • 100
    Emsley J. Parfum, Portwein, PVC…Chemie im Alltag, 1st edn. Weinheim: Wiley-VCH, 2003.
  • 101
    Gower D B, Nixon A, Jackman P J A, Mallet A I. Transformation of steroids by axillary coryneform bacteria. Int J Cosmetic Sci 1986: 8: 149158.
  • 102
    Brennan P A, Zufall F. Pheromonal communication in vertebrates. Nature 2006: 444: 308315.
  • 103
    Kimoto H, Haga S, Sato K, Touhara K. Sex-specific peptides from exocrine glands stimulate mouse vomeronasal sensory neurons. Nature 2005: 437: 898901.
  • 104
    Penn D J, Oberzaucher E, Grammer K et al. Individual and gender fingerprints in human body odour. J Roy Soc Interface 2007: 4: 331340.
  • 105
    Penn D, Potts W K. Untrained mice discriminate MHC-determined odors. Physiol Behav 1998: 64: 235243.
  • 106
    Zouboulis C C, Eady A, Philpott M et al. What is the pathogenesis of acne? Exp Dermatol 2005: 14: 143152.
  • 107
    Klapproth H, Reinheimer T, Metzen J et al. Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn-Schmiedeberg’s Arch Pharmacol 1997: 355: 515523.
  • 108
    Seifert M, Rech M, Meineke V, Tilgen W, Reichrath J. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro. J Steroid Biochem Mol Biol 2004: 90: 375379.